Shah Gaurav insider trades
Shah Gaurav has filed 31 Form 4s with the SEC that we hold, for Rocket Pharmaceuticals, INC. (RCKT) (CEO) and TALS (Director). Across all of them we count 2 purchases worth $483.1K and 18 sales worth $2.0M reported on Form 4. In the last 12 months: 0 purchases ($0) and 8 sales ($285.9K). The largest single trade was a sale of 20,272 shares of Rocket Pharmaceuticals, INC. worth $604.9K, dated 2024-02-16. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-02-08 and the latest 2026-08-20.
Rocket Pharmaceuticals, INC. (RCKT)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-02-07 | P, purchase reported on Form 4 | 22,000 | $381.5K | 2022-02-08 | SEC |
| 2023-02-17 | S, sale reported on Form 4 | 12,194 | $232.4K | 2023-02-22 | SEC |
| 2023-05-17 | S, sale reported on Form 4 | 4,122 | $88.1K | 2023-05-19 | SEC |
| 2023-08-17 | S, sale reported on Form 4 | 4,767 | $73.7K | 2023-08-21 | SEC |
| 2024-02-16 | S, sale reported on Form 4 | 20,272 | $604.9K | 2024-02-21 | SEC |
| 2024-05-16 | S, sale reported on Form 4 | 9,790 | $228.6K | 2024-05-20 | SEC |
| 2024-08-16 | S, sale reported on Form 4 | 9,650 | $178.5K | 2024-08-20 | SEC |
| 2024-11-21 | S, sale reported on Form 4 | 11,091 | $144.7K | 2024-11-25 | SEC |
| 2025-02-21 | S, sale reported on Form 4 | 16,303 | $172.5K | 2025-02-25 | SEC |
| 2025-04-10 | P, purchase reported on Form 4 | 20,000 | $101.6K | 2025-04-14 | SEC |
| 2025-05-16 | S, sale reported on Form 4 | 3,621 | $23.6K | 2025-05-20 | SEC |
| 2025-05-20 | S, sale reported on Form 4 | 2,253 | $14.5K | 2025-05-22 | SEC |
| 2025-11-18 | S, sale reported on Form 4 | 6,276 | $18.7K | 2025-11-20 | SEC |
| 2026-02-13 | S, sale reported on Form 4 | 12,279 | $40.6K | 2026-02-18 | SEC |
| 2026-02-18 | S, sale reported on Form 4 | 5,990 | $20.0K | 2026-02-20 | SEC |
| 2026-05-13 | S, sale reported on Form 4 | 2,728 | $9.8K | 2026-05-14 | SEC |
| 2026-05-19 | S, sale reported on Form 4 | 2,409 | $7.3K | 2026-05-21 | SEC |
| 2026-05-21 | S, sale reported on Form 4 | 55,684 | $172.1K | 2026-05-26 | SEC |
| 2026-08-13 | S, sale reported on Form 4 | 2,837 | $9.6K | 2026-08-17 | SEC |
| 2026-08-18 | S, sale reported on Form 4 | 2,293 | $7.8K | 2026-08-20 | SEC |
TALS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1725922) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
